from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3388/PE_PGRS52

LFCtreatmentdescriptionclass of inhibitor

2.544

Amikacinug/mL Amikacintranslation

1.972

Cap5-10ug/mL Capreomycintranslation

4.127

Rox10-50 ug/mL Roxithromycintranslation

-0.261

SM2-5 ug/mL Streptomycintranslation

3.477

Tet5-10 ug/mL Tetracyclinetranslation

-0.141

Rif0.2-5ug/mL Rifampicintranscription

-2.188

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.572

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.061

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.141

CPZ10-50 ug/mL Chlorpromazinerespiration

0.263

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.747

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.122

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.831

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.453

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.740

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.080

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.102

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.350

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.627

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.760

KCN5-20 ug/mL Potassium cyaniderespiration

-0.261

NaN30.2-2 mM Sodium aziderespiration

0.933

Nigericin50 uM Nigericinrespiration

-0.642

TRC10-150 ug/mL Triclosanrespiration

-0.188

TRZ10-25 ug/mL Thioridazinerespiration

1.043

Valinomycin0.5-10 uM Valinomycinrespiration

-0.941

ZnSO42 mM ZnSO4respiration

-0.242

menadione6-10 ug/mL Menadionerespiration

-0.026

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.773

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.339

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.718

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.778

NRP_1Non-replicating persistence stage 1dosRassociated

-0.233

Amp0.2mg/mL AmpicillincellWall

-0.620

Cephalexin20-100 ug/mL CephalexincellWall

-0.864

Cerulenin0.32-5 ug/mL CerulenincellWall

0.385

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.455

EMB10-20 ug/mL EthambutolcellWall

-0.708

Eta12-40 ug/mL EthionamidecellWall

-0.280

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.747

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.291

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.270

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.022

BZA0.12 mg/mL BenzamidearomaticAmides

0.367

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.321

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.042

H2O24 mM hydrogen peroxideDNAdamaging

-0.769

Levo10 ug/mL LevofloxacinDNAdamaging

-0.173

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.371

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.458

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.361

UVUV-irradiationDNAdamaging

0.294

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.768

Antimycin12.5-50 ug/mL Antimycin A?

-0.805

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.155

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.976

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.347

PA8240.2-2 ug/mL PA-824?

0.530

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.252

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.519

Verapamil50 uM Verapamil?

-0.518

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.565

methoxatin10-20 ug/mL Methoxatin?